HLIO(HLIO)
HLIO
Q4 2026 EPS Estimate
$0.68
Nov 2, 2026 · Reports after close
Revenue Estimate
$220M
FY2027E EPS$2.94
FY2028E EPS$3.36
Analyst Sentiment
Wall St. Consensus
Buy13 analysts·Moderate coverage
63
Score
7 Buy (54%)6 Hold (46%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
754%
Hold
646%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$85.00
+4.1%
Consensus
$95.00
+16.3%
Bull
$95.00
+16.3%
12-Month Target Range13 analysts
$85.00$95.00$95.00
Current $81.67Consensus
Current Price
$81.67
Upside to Consensus
$13.33
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+5.22%
EPS+16.25%
FY2028
Rev+5.24%
EPS+14.33%
FY2029
Rev+5.33%
EPS+12.32%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $868M | $914M | $963M | $1.02B | $1.08B |
| Low | $861M | $896M | $949M | $1.01B | $1.07B |
| High | $873M | $934M | $974M | $1.03B | $1.09B |
| EBITDA Avg | $170M | $179M | $189M | $200M | $212M |
| Low | $169M | $176M | $186M | $197M | $209M |
| High | $171M | $183M | $191M | $202M | $214M |
| EBIT Avg | $109M | $115M | $121M | $128M | $136M |
| Low | $108M | $113M | $119M | $126M | $134M |
| High | $110M | $117M | $122M | $130M | $138M |
| Net Income Avg | $98M | $111M | $126M | $143M | $161M |
| Low | $96M | $109M | $123M | $140M | $158M |
| High | $98M | $116M | $128M | $145M | $163M |
| EPS Avg | $2.94 | $3.36 | $3.77 | $4.29 | $4.83 |
| Low | $2.89 | $3.26 | $3.70 | $4.21 | $4.75 |
| High | $2.96 | $3.47 | $3.83 | $4.36 | $4.91 |
| Analysts (Rev / EPS) | 5 / 4 | 4 / 3 | 1 / 1 | 1 / 1 | 1 / 1 |
Quarterly
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|
| Revenue Avg | $208M | $201M | $237M | $241M | $215M | $220M |
| Low | $204M | $197M | $232M | $235M | $210M | $215M |
| High | $214M | $209M | $246M | $250M | $223M | $228M |
| EBITDA Avg | $41M | $39M | $47M | $47M | $42M | $43M |
| Low | $40M | $39M | $45M | $46M | $41M | $42M |
| High | $42M | $41M | $48M | $49M | $44M | $45M |
| EBIT Avg | $26M | $25M | $30M | $30M | $27M | $28M |
| Low | $26M | $25M | $29M | $30M | $26M | $27M |
| High | $27M | $26M | $31M | $31M | $28M | $29M |
| Net Income Avg | $23M | $21M | $28M | $32M | $27M | $28M |
| Low | $22M | $21M | $27M | $31M | $26M | $27M |
| High | $25M | $22M | $30M | $33M | $28M | $30M |
| EPS Avg | $0.69 | $0.64 | $0.85 | $0.95 | $0.80 | $0.85 |
| Low | $0.65 | $0.62 | $0.82 | $0.92 | $0.78 | $0.82 |
| High | $0.74 | $0.68 | $0.89 | $1.00 | $0.84 | $0.89 |
| Analysts (Rev / EPS) | 4 / 4 | 3 / 2 | 3 / 2 | 3 / 2 | 3 / 2 | 2 / 3 |